Long-Acting Risperidone: A Review of Its Use in Schizophrenia

Author： Tracy Swainston Harrison   Goa K.L.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.2, 2004-01, pp. : 113-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Olanzapine Long-Acting Injection: A Review of its Use in the Treatment of Schizophrenia

By Frampton James E.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2289-2313

Adis International

Access to resources Recommend Favorite

Spotlight on Long-Acting Risperidone in Schizophrenia

By Tracy Swainston Harrison   Karen L. Goa  

American Journal of Drug Delivery, Vol. 2, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Long-acting risperidone adds value in schizophrenia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 443, 2003-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Long-acting risperidone most economical choice in schizophrenia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 477, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Long-acting risperidone adds value in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite